To Enquire About

the Report Click

Here

IndustryARC

Global Injectable Drug Delivery Market

By Devices, Therapeutics & Formulations [Self-Injection Devices (Pen, Needle Free

& Auto Injectors), Auto-Immune Diseases, Diabetes, Oncology, Hormonal Disorders,
Liposomes, Microspheres, Nanoparticles, Polymeric Micelles] (2015 2020)

To Enquire About
the Report Click
Here

TABLE OF CONTENTS
1. Market Overview
2. Executive Summary
3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1.

Product Benchmarking

3.2.2.

End user profiling

3.2.3.

Patent Analysis

3.2.4.

Top 5 Financials Analysis

4. Global Injectable Drug Delivery - Market Forces

4.1. Market Drivers
4.1.1.

Inherent Use Case Scenario of IDD Devices With Biologics

4.1.2.

Increase in Global Diabetic Population and Usage of Insulin Pens

4.1.3.

Others

4.2. Market Constraints

4.2.1.

Infection Risks And Government Laws

4.2.2.

Others

4.3. Market Challenges

4.3.1.

Higher Manufacturing Standards Needed to Avoid Product Recalls

4.3.2.

Others

4.4. Attractiveness of the Industry

4.4.1.

Power of Suppliers

4.4.2.

Power of Customers

4.4.3.

Threat of New entrants

To Enquire About
the Report Click
Here

4.4.4.

Threat of Substitution

4.4.5.

Degree of Competition

5. Global Injectable Drug Delivery Market Strategic Analysis

5.1. Value Chain Analysis
5.2. Opportunities Analysis
5.3. Product/Market Life Cycle Analysis
6. Global Injectable Drug Delivery Market By Type
6.1. Pharmaceutical Drug Formulations
6.2. By Device
6.2.1.

Conventional Devices

6.2.2.

Auto Injector Devices

6.2.3.

Self-Injector Devices

6.2.4.

Pen Injectors

6.2.5.

Needle Free Injector Devices

6.3. Others
7. Global Injectable Drug Delivery Market - By Type of Diseases
7.1. Anemia
7.2. Diabetes
7.3. Multiple sclerosis
7.4. Rheumatoid
7.5. Crohn's
7.6. Others
8. Global Injectable Drug Delivery Market -Geographic Analysis
8.1. Introduction
8.2. North America

To Enquire About
the Report Click
Here

8.2.1.

Canada

8.2.2.

Haiti

8.2.3.

Mexico

8.2.4.

USA

8.2.5.

Others

8.3. South & Central America

8.3.1.

Argentina

8.3.2.

Brazil

8.3.3.

Chile

8.3.4.

Colombia

8.3.5.

Venezuela

8.3.6.

Others

8.4. Europe
8.4.1.

Germany

8.4.2.

France

8.4.3.

Italy

8.4.4.

Russia

8.4.5.

Spain

8.4.6.

Turkey

8.4.7.

U.K

8.4.8.

Others

8.5. APAC
8.5.1.

Bangladesh

8.5.2.

China

8.5.3.

India

To Enquire About
the Report Click
Here

8.5.4.

Nepal

8.5.5.

Srilanka

8.5.6.

Singapore

8.5.7.

Malaysia

8.5.8.

Others

8.6. ROW
9. Market Entropy
9.1. New Product Launches
9.2. M&As, Collaborations, JVs and Partnerships
10. Company Profiles (Overview, Financials, SWOT Analysis Top 5 Companies,
Developments, Product Portfolio)
10.1. Becton Dickinson and Company (BD)
10.2. Baxter International Inc.
10.3. Consort Medical PLC
10.4. Crossject SA
10.5. Eli Lilly and Company
10.6. Elcam Medical
10.7. Novo Nordisk
10.8. Owen Mumford Ltd
10.9. Sanofi
10.10. Schott AG
10.11. Terumo Corporation
10.12. Ypsomed Holding AG
10.13. Others
11. Appendix
11.1. Abbreviations

To Enquire About
the Report Click
Here

11.2. Sources
11.3. Research Methodology
11.4. Bibliography
11.5. Compilation of Expert Insights
11.6. Disclaimer

To Enquire About
the Report Click
Here

1. GLOBAL INJECTABLE DRUG DELIVERY DEVICES

MARKET OVERVIEW
1.1 REPORT SCOPE
The global injectable drug delivery devices market has been analyzed with respect to the demand for
devices from different countries across the globe. These markets are broken down into segments
and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012, and forecast
to 2020. The drug injection devices market has been segmented into conventional injectors and selfinjection devices broadly. Similarly the drug formulations market has been segmented into the
conventional drugs and novel drugs segments. The therapeutic areas are further segmented and
analyzed in this report.
While conventional devices are growing at a CAGR of 7.37%, self-injection devices are expected to
grow at 16.6% during 2013 2018. Conventional injection devices hold around 87% market share
currently but this is expected to decrease to around 83% by 2018, as the use of self-injection devices
increases in the next 5 years.
The global injectable drug delivery devices market is expected to increase from around $11.6bn in
2013 to around $17.5bn in 2018. Self-injection devices are expected to grow at the highest growth
rate of 16.1% with conventional injection devices growing at only 7.4% during the forecast period
2013 2018.
Analyzing the competitive landscape of the global conventional injectable devices market for 2012
IndustryARC is of the opinion that Becton Dickinson & Co. had the top position with a market
share of around 27% followed by Baxter International Inc with a share of 23%. Overall these two
companies along with Terumo Corporation and Schott AG together held market share of around
85%.

To Enquire About
the Report Click
Here

SAMPLE DATA
SAMPLE FIGURE: EUROPEAN INSULIN CARTRIDGES MARKET, BY
VOLUME -3ML (MU) BY COUNTRY, 2013

Russian Federation
Germany
Turkey
UK
Italy

SAMPLE TABLE: INJECTABLE DRUG DELIVERY DEVICES - GLOBAL MARKET,

BY TYPE OF DEVICE ($ MILLION) - 2011 - 2020
Type of Device

Auto Injector Devices

Conventional Devices
Self-Injector Devices
Pen Injectors
Needle Free Injector
Devices
Total

2011

2012

2013

2020

CAGR (%)

xx
xx
800
xx
xx

xx
xx
933
xx
xx

xx
xx
1088
xx
xx

xx
xx
3187
xx
xx

2013-2020
xx
xx
16.6
xx
xx

xx

xx

xx

xx

xx

To Enquire About
the Report Click
Here

KEY MARKET INSIGHTS

1.

More than 50% of the new drugs will be delivered by injection in the next 10 years.

2.

Demand for Needle free injection devices which can inject drugs with minimum or no pain
is expected to see strong growth in the next 5 years.

3.

Newer technologies like injectable smart sponge, electronically controlled pills,

biocompatable and biodegradable hydrogels are being tested for commercial purposes and
their arrival can offer better and accurate drug delivery products.

4.

Injectable biologics is a key segment driving the growth of injectable drug devices market;
they are largely used for the treatment of serious medical conditions.

5.

North America and Europe together account for more than 65% of the market share of
injectable drug devices market in 2013.

6.

Novo Nordisk, Eli Lilly & Sanofi-Aventis are aggressively increasing their Insulin cartridges
production volumes.

To Enquire About
the Report Click
Here

RESEARCH METHODOLOGY
The quantitative and qualitative data collected for the IDD report is from a combination of
secondary and primary sources. Research interviews were conducted with senior executives
and/or mangers in the IDD Industry. These Key Opinion Leaders (KOLs) were then
provided a questionnaire to gather quantitative and qualitative inputs on their operations,
performance, strategies and views on the overall market, including key developments and
technology trends. Data from interviews is consolidated, checked for consistency and
accuracy, and the final market numbers are again validated by experts. The global market was
split by product types and geography based on different factors like primary and secondary
sources, understanding of the number of companies operating in each segment and also KOL
insights.
We have used various secondary sources such as directories, articles, white papers,
newsletters, annual reports and paid databases such as OneSource, Hoovers and Factiva to
identify and collect information for extensive technical and commercial study of the IDD
market.
The approach towards finding information regarding the market and forecasting has been
quite extensive. Since the amount of materials consumed for additive manufacturing depend
almost entirely on the number of battery shipments across the world, we have taken this to be
our hypothesis.. This, when combined with the Average Selling Price (ASP) of the various
materials under consideration, has led us to the revenues of different segments. The market
has then been forecast according to the market trend shown by the sales of major players like
Maxwell Technologies Inc. (U.S.), Nesscap Co. Ltd. (South Korea), Cap-XX (Australia)
Panasonic Electronic Devices Co. Ltd. (Japan) and also considering new developments.
The key players in the market and its value chain were identified through secondary research
and their market opinions were also gathered in a similar way through telephonic interviews
and questionnaires. We have also studied the annual reports of these top market players.
Interviews with key opinion leaders such as directors, managers, and marketing personnel
were used extensively in understanding the need and emergence of IDD market.
We also have extensive database of contacts which were used to conduct primary interviews
and also to get their inputs using questionnaires.

To Enquire About
the Report Click
Here

THE ARC ADVANTAGE

An analytical model lies at the core of our process, ensuring logical consistency
throughout our research. We complement the model with secondary data and
interviews with industry experts to reflect the latest trends. With our final expert
validation, we provide you with only the most accurate and actionable intelligence.

THE ARC PROCESS

Analytical
Method
1. Granular
breakdown of
drivers into
factors
2. Validate all
factors in terms
of their present
impact on the
market
3. Assign weights
to these factors in
terms of their
relevance and
impact on the
market
4. Build the
Analytical Model
ANALYTICAL MODEL

Base Method

1. Get a topdown estimate of

the market
2. Follow it up
with a bottom-up
estimate of the
market
3. Check
forconsistency
and new growth
factors that are
relevant over the
next 10 Years

4. Build the Base

model
BASE MODEL

Consolidation
Method
1. Granular
breakdown of
drivers into
factors
2. Validate all
factors in terms
of their present
impact on the
market.
3. Assign weights
to these factors in
terms of their
relevance and
impact on the
market.
4. Build the
Consolidated
Model

Delphi
Verification
1. Verify the
findings of the
model with
experts from
across the value
chain
2. Verify the
findings with
players across
small and large
enterprises
3. Tweak the
model and add
new factors
4. Finalize the
ARC Model

CONSOLIDATED MODEL

ARC MODEL

To Enquire About
the Report Click
Here

ABOUT US
IndustryARC was started by a group of young, passionate professionals along with
extensively experienced industry veterans across various business segments. Our focus and
expertise is mainly in the field of analytics, market research and consulting. Our singular
goal is to provide accurate and affordable research to our clients.
Our research team has expertise in diverse fields like Healthcare, Chemicals,
Manufacturing, Logistics, Electronics and Automotive. However diverse the expertise
maybe, everyone in our team shares one common trait - we love data and we love
providing solutions to clients using that data even more! Seeing your business flourish
based on our solutions and strategy is what we love the most!
Industry ARC publishes more than 30 reports on an annual basis in the mentioned five
Industries. Our reports are in-depth and high quality reports that can help decision makers
frame better strategies for their business requirements. These reports can be further
customized as per your needs.
Disclaimer:

The reports sold by IndustryARC are limited publications containing valuable

market information provided to a select group of customers in response to orders.

Our customers acknowledge and agree that any report bought from IndustryARC is
for their own internal use and not for general publication or disclosure to third
parties.

Our reports or part of the reports, information contained in the report, cannot be
shared or resold to any other third party.

Disclosure to third parties, usage of data in a public document, article or blog by the
customer can be done with prior permission taken from IndustryARC.

For information regarding permissions and sales, contact:

sales@industryarc.com | sanjay.matthews@industryarc.com

To Enquire About
the Report Click
Here

IndustryARC
+1 585 - 331 - 8686
sales@industryarc.com

Copyright 2015 IndustryARC

All Rights Reserved. This document contains highly confidential information and is the sole
property of IndustryARC. No part of it may be circulated, copied, quoted, or otherwise
reproduced without the approval of IndustryARC.